Galectin Therap
GALT----
Galectin Therap (GALT)
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in drug development to create new therapies for fibrotic disease and cancer. The...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Galectin Therap Analyst Rating
View MoreForecast & Rating
Jun 23, 2026Price forecast
$11.00211.61%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · Jul 14 at 12:05 PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
- Price Alert · Jul 14 at 10:53 AM
U.S. stock market midday update: Galectin Therap up 16.74%, active funds but no news catalyst
- PUBT · Jul 14 at 08:53 AM
Galectin Therapeutics posts corporate presentation highlighting belapectin program for MASH cirrhosis, portal hypertension
- rttnews · Jul 13 at 09:35 PM
Top Biotech Gainers: QTTB Sends Strong SIGNAL; AMWL And SI In Focus
- PUBT · Jun 30 at 06:23 PM
Galectin Therapeutics CMO Jamil Khurram disposes of common shares worth $262,943
- benzinga_article · Jun 30 at 07:55 AM
Top 3 Health Care Stocks That May Keep You Up At Night In June
